Requisition Notice

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

Cathay International Holdings Limited

("Cathay" or the "Company")

Requisition Notice Received by the Company

Hong Kong, 29 September 2020 - Cathay International Holdings Ltd. (LSE: CTI.L), an operator and investor in the healthcare sector in the People's Republic of China (the "PRC"), announces that on 28 September 2020 it received a notice from Circle Finance Limited and Mega Worldwide Services Limited, the holders of in aggregate 1,373,940,837 Common Shares of USD 0.01 each ("Common Shares") and 8,249,276 A Shares of USD 0.01 each ("A Shares" and together with the Common Shares, the "the "Shares"), requisitioning a general meeting of the Company's shareholders (the "Requisition Notice"). The Requisition Notice proposes resolutions (i): (a) to approve of the cancellation of the Company's listing (i.e. admission of its Common Shares to the official list of the FCA), and the cancellation of the admission of the Common Shares to trading on the main market of the London Stock Exchange, (the "Listing Cancellation"); and (b) to direct the directors of the Company (the "Directors") to take any and all actions required or reasonably necessary to effect the Listing Cancellation, and to make all associated notifications and announcements as may be reasonably required to effect the Listing Cancellation; and (ii) subject to the approval of resolution (i), to approve the adoption of a set of amended and restated bye-laws of the Company. In addition to the Requisition Notice, Circle Finance Limited has provided a letter of undertaking ("Letter of Undertaking"), setting out an irrevocable commitment, which is subject to the Listing Cancellation being approved by shareholders of the Company and becoming effective, to fund the payment for an exit opportunity available for all shareholders of the Company who wish to offer to sell their Shares for cash at a maximum price of 1.7p per Share on certain terms and conditions.

The board of Directors is considering the contents of the Requisition Notice and Letter of Undertaking and will make further detailed announcements as appropriate.

Shareholders are advised that there is no certainty that the proposed Listing Cancellation will proceed or that the Letter of Undertaking will result in an exit opportunity being crystalised, or to the timing of such, and therefore to take precaution in dealing in the Company's shares.

-Ends-

For further enquiries, please contact:

About Cathay

Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and an operator and investor in the healthcare sector in the People's Republic of China (the "PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on investment opportunities in the growing domestic demand for high quality healthcare products in the PRC and build portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a track record of identifying investment opportunities in this area including: Lansen, a leading specialty pharmaceutical company focused on rheumatology and dermatology in the PRC; Haizi, a company engaged in the manufacture, marketing and sale of inositol and its by-product, di-calcium phosphate; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.

The Group employs approximately 1,300 people across the PRC, including over 20 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk.